Digital Holter measurement of QT prolongation in ziprasidone overdose

Clinical Toxicology

Volumn 49, Issue 7, 2011, Pages 694-696

  Berling, Ingrid ^a   Isbister, Geoffrey K ^a,b   Calver, Leonie ^b   Clunas, Sally ^b  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Diagnosis; Electrocardiography; Humans; Long QT syndrome; Overdose; Ziprasidone

Indexed keywords

DIAZEPAM; ELECTROLYTE; PROPRANOLOL; VENLAFAXINE; ZIPRASIDONE;

ADULT; ARTICLE; BRADYCARDIA; CASE REPORT; DRUG OVERDOSE; ELECTROCARDIOGRAM; FEMALE; GOLD STANDARD; HEART RATE; HOLTER MONITORING; HUMAN; NOMOGRAM; QT INTERVAL; QT PROLONGATION; TELEMETRY;

ACTION POTENTIALS; ANTIPSYCHOTIC AGENTS; BRADYCARDIA; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; KINETICS; MIDDLE AGED; OVERDOSE; PIPERAZINES; PREDICTIVE VALUE OF TESTS; TELEMETRY; THIAZOLES;

EID: 80052444555     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2011.597035     Document Type: Article

References (10)

1. Pfi zer. Geodon (ziprasidone HCl) Dear Healthcare Professional Letter, March 2002.
2. Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007;100:609-615. (Pubitemid 47543415)
3. Oldham MA, Catalano G, Catalano MC, Ross MM. QTc prolongation associated with ziprasidone overdose. CNS Spectr 2008;13:E1.
4. Manini AF, Rasberry D, Hoffman RS, Nelson LS. QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine. J Med Toxicol 2007;3:178-181.
5. Alipour A, Cruz R, Lott RS. Torsade de pointes after ziprasidone overdose with coingestants. J Clin Psychopharmacol 2010; 30:76-77.
6. Heinrich TW, Biblo LA, Schneider J. Torsades de pointes associated with ziprasidone. Psychosomatics 2006; 47:264-268. (Pubitemid 46940487)
7. Burton S, Heslop K, Harrison K, Barnes M. Ziprasidone overdose. Am J Psychiatry 2000; 157:835.
8. LoVecchio F, Watts D, Eckholdt P. Three-year experience with ziprasidone exposures. Am J Emerg Med 2005;23:586-587.
9. Hnatkova K, Gang Y, Batchvarov VN, Malik M. Precision of QT interval measurement by advanced electrocardiographic equipment. PACE 2006;29:1277-1284. (Pubitemid 44707113)
10. Isbister GK, Calver L, Van Gorp F, Stokes B, Page CB. Inter-rater reliability of manual QT measurement and prediction of abnormal QT, HR pairs. Clin Toxicol 2009; 47:884-888.